Clinical efficacy of dim light melatonin onset testing in diagnosing delayed sleep phase syndrome

Sleep Medicine

Volumn 10, Issue 5, 2009, Pages 549-555

  Rahman, Shadab A ^a,b   Kayumov, Leonid ^a   Tchmoutina, Ekaterina A ^a   Shapiro, Colin M ^a,c,d,e  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e Youthdale Child and Adolescent Sleep Centre   (Canada)

Author keywords

Circadian rhythm disorder; DLMO; DSPS; Melatonin; Polysomnography sleep studies; Sleep disorders

Indexed keywords

MELATONIN;

ADULT; ARTICLE; CIRCADIAN RHYTHM SLEEP DISORDER; CLINICAL ASSESSMENT TOOL; DELAYED SLEEP PHASE SYNDROME; DIFFERENTIAL DIAGNOSIS; DIM LIGHT MELATONIN ONSET TEST; FEMALE; HORMONE DETERMINATION; HORMONE RELEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; NIGHT SLEEP; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SLEEP DISORDER; SLEEP PATTERN; SYMPTOM;

ADOLESCENT; ADULT; CIRCADIAN RHYTHM; COHORT STUDIES; FEMALE; HUMANS; LIGHT; MALE; MELATONIN; POLYSOMNOGRAPHY; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SALIVA; SLEEP DISORDERS, CIRCADIAN RHYTHM; YOUNG ADULT;

EID: 67349158266     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2008.03.020     Document Type: Article

References (39)

1. Dagan Y., and Eisenstein M. Circadian rhythm sleep disorders: toward a more precise definition and diagnosis. Chronobiol Int 16 2 (1999) 213-222
2. Schrader H., Bovim G., and Sand T. The prevalence of delayed and advanced sleep phase syndromes. J Sleep Res 2 1 (1993) 51-55
3. Regestein Q.R., and Monk T.H. Delayed sleep phase syndrome: a review of its clinical aspects. Am J Psychiatry 152 4 (1995) 602-608
4. Dagan Y. Circadian rhythm sleep disorders (CRSD). Sleep Med Rev 6 1 (2002) 45-54
5. Kayumov L., Brown G., Jindal R., Buttoo K., and Shapiro C.M. A randomized, double-blind, placebo-controlled crossover study of the effect of exogenous melatonin on delayed sleep phase syndrome. Psychosom Med 63 1 (2001) 40-48
6. Grosse J., and Davis F.C. Melatonin entrains the restored circadian activity rhythms of syrian hamsters bearing fetal suprachiasmatic nucleus grafts. J Neurosci 18 19 (1998) 8032-8037
7. Arendt J. Melatonin and human rhythms. Chronobiol Int 23 1-2 (2006) 21-37
8. Kayumov L., Zhdanova I.V., and Shapiro C.M. Melatonin, sleep, and circadian rhythm disorders. Semin Clin Neuropsychiatry 5 1 (2000) 44-55
9. Lewy AJ C.N., and Sack R.L. The endogenous melatonin profile as a marker for circadian phase position. J Biol Rhythms 14 3 (1999) 227 36
10. Wyatt J.K. Delayed sleep phase syndrome: pathophysiology and treatment options. Sleep 27 6 (2004) 1195-1203
11. Kamei Y., Urata J., Uchiyaya M., Hayakawa T., Ozaki S., Shibui K., et al. Clinical characteristics of circadian rhythm sleep disorders. Psychiatry Clin Neurosci 52 2 (1998) 234-235 Apr
12. Association. DCSCotASD. The international classification of sleep disorders: diagnostic and coding manual. Rochester, MN; 1990.
13. Association AP. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC; 1995.
14. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1 3 (1977) 385-401
15. Fleming J.S., and Courtney B.E. The dimensionality of self-esteem: II. Hierarchical facet model for revised measurement scales. J Pers Soc Psychol 46 2 (1984) 404-421
16. Zung W. A rating instrument for anxiety disorders. Psychosomatics 12 6 (1971) 371-379
17. Johns M.W. Reliability and factor analysis of the epworth sleepiness scale. Sleep 15 4 (1992) 376-381
18. Johns M.W. Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the epworth sleepiness scale: failure of the MSLT as a gold standard. J Sleep Res 9 1 (2000) 5-11
19. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques, and scoring systems for sleep stages of human subjects. Los Angeles, CA: Brain Information/Brain Research Institute UCLA; 1968.
20. Krupp L.B., LaRocca N.G., Muir-Nash J., and Steinberg A.D. The fatigue severity scale application to patents with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46 (1989) 1121-1123
21. Hoddes E., Zarcone V., Smythe H., Phillips R., and Dement W.C. Quantification of sleepiness: a new approach. Psychophysiology 10 4 (1973) 431-436
22. Taylor G.J., Ryan D., and Bagby R.M. Toward the development of a new self-report alexithymia scale. Psychother Psychosom 44 4 (1985) 191-199
23. Shapiro C.M., Auch C., Reimer M., Kayumov L., Heslegrave R., Huterer N., et al. A new approach to the construct of alertness. J Psychosom Res 60 6 (2006) 595-603
24. Kayumov L., Lowe A., Rahman S.A., Casper R.F., and Shapiro C.M. Prevention of melatonin suppression by nocturnal lighting: relevance to cancer. Eur J Cancer Prev 16 4 (2007) 357-362
25. Kayumov L., Casper R.F., Hawa R.J., Perelman B., Chung S.A., Sokalsky S., et al. Blocking low-wavelength light prevents nocturnal melatonin suppression with no adverse effect on performance during simulated shift work. J Clin Endocrinol Metab 90 5 (2005) 2755-2761
26. Nagtegaal E., Peeters T., Swart W., Smits M., Kerkhof G., and van der Meer G. Correlation between concentrations of melatonin in saliva and serum in patients with delayed sleep phase syndrome. Ther Drug Monit 20 2 (1998) 181-183
27. Martin S.K., and Eastman C.I. When is your DLMO?. Sleep 23 (2000) A179
28. Alberg A.J., Park J.W., Hager B.W., Brock M.V., and Diener-West M. The use of "Overall Accuracy" to evaluate the validity of screening or diagnostic tests. J Gen Intern Med 19 (2004) 460-465
29. Agnew Jr. H.W., Webb W.B., and Williams R.L. The first night effect: an EEG study of sleep. Psychophysiology 2 3 (1966) 263-266
30. Lam R.W. Sleep disturbances and depression: a challenge for antidepressants. Int Clin Psychopharmacol 21 Suppl. 1 (2006) S25-S29
31. Wirz-Justice A., and Van den Hoofdakker R.H. Sleep deprivation in depression: what do we know, where do we go?. Biol Psychiatry 46 4 (1999) 445-453
32. Fuchs E., Simon M., and Schmelting B. Pharmacology of a new antidepressant: benefit of the implication of the melatonergic system. Int Clin Psychopharmacol 21 Suppl. 1 (2006) S17-S20
33. Goldman B.D. Pattern of melatonin secretion mediates transfer of photoperiod information from mother to fetus in mammals. Sci STKE 2003 192 (2003) PE29
34. Doghramji K. Melatonin and its receptors: a new class of sleep-promoting agents. J Clin Sleep Med 3 5 Suppl. (2007) S17-S23
35. Lavie P. Sleep-wake as a biological rhythm. Annu Rev Psychol 52 (2001) 277-303
36. Watanabe T., Kajimura N., Kato M., Sekimoto M., Nakajima T., Hori T., et al. Sleep and circadian rhythm disturbances in patients with delayed sleep phase syndrome. Sleep 26 6 (2003) 657-661
37. Pandya R., Metz L., and Patten S.B. Predictive value of the CES-D in detecting depression among candidates for disease-modifying multiple sclerosis treatment. Psychosomatics 46 2 (2005) 131-134
38. Koide Y., Yotsukura M., Yoshino H., and Ishikawa K. Usefulness of QT dispersion immediately after exercise as an indicator of coronary stenosis independent of gender or exercise-induced ST-segment depression. Am J Cardiol 86 12 (2000) 1312-1317
39. Cole L.A., Sutton-Riley J.M., Khanlian S.A., Borkovskaya M., Rayburn B.B., and Rayburn W.F. Sensitivity of over-the-counter pregnancy tests: comparison of utility and marketing messages. J Am Pharm Assoc 45 5 (2003) 608-615